Skip Navigation

European Heart Journal 2002 23(24):1892-1893; doi:10.1053/euhj.2002.3348
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fox, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fox, K. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Familial hypercholesterolaemia—screening is effective, but is it cost effective?

K. F. Fox

Cardiovascular Medicine, Faculty of Medicine, Imperial College of Science Technology and Medicine at Charing Cross Hospital, London, UK

References

  1. Wood DA, Durrington P, Poulter N, McInnes G, Rees A, Wray R. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart. 1999;80:S1–S26
  2. Wilson, J, Jungner, YG, Principles and practice of mass screening for disease, 65(iv), Geneva, WHO, 1968
  3. Bhatnagar D, Morgan J, Siddiq S, Mackness MI, Miller JP, Durrington P. Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia. BMJ. 2000;321:1–5[Free Full Text]
  4. Umens-Eckenhausen MAW, Defeshe JC, Sijbrands EJG, Scheerder RLJM, Kastelein JJP. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet. 2001;357:165–168[CrossRef][Web of Science][Medline]
  5. Durrington P. Rigorous detection and vigorous treatment of familial hypercholesterolaemia. Lancet. 2001;357:574[Medline]
  6. Atherosclerosis. 1999;142:105–112[CrossRef][Web of Science][Medline]
  7. Marang-van de Mheen PJ, ten Asbroek AHA, Bonneux L, Bonsel GJ, Klazinga NS. Cost-effectiveness of a family based DNA based screening program on familial hypercholesterolaemia in the Netherlands. Eur Heart J. 2002;23:1922–1930[Abstract/Free Full Text]
  8. Marks D, Wonderling D, Thorogood M, Lambert H, Humphries SE, Neil HAW. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2000;4:1–123[Medline]
  9. Wood DA, De Backer G, Faergeman O, Graham IM, Mancia G, Pyörälä K. Prevention of coronary disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J. 1998;19:1434–1503[Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fox, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fox, K. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?